CD4 and COVID-19: In this study, we collected blood from virus-free COVID-19 convalescent individuals to explore the immune response of host cells, and analyzed their SARS-CoV-2-specific antibody and the response of CD4+, CD8+, and natural killer (NK) cells to SARS-CoV-2 antigen peptide pools.